A year ago this month...
The Seattle Times published an investigative series that reported that patients in two unsuccessful clinical trials at the Fred Hutchinson Cancer Research Center had been deprived of critical information before they enrolled in the experiments.
Since then, officials at "The Hutch" and their supporters have railed against the reports, challenging their fairness and accuracy. The Times has published their questions and complaints and has responded to them in the pages of this newspaper.
In that spirit, we are reprinting an opinion column first published Tuesday in The Wall Street Journal. The column was written by Laura Landro, a Journal editor whose cancer was successfully treated at The Hutch in 1992 and who since has been a major benefactor. She and her husband have established an endowment that has funded clinical research at the center.
With Landro's column is a response from the executive editor of The Times, Michael R. Fancher.
|LAURA LANDRO'S COLUMN||THE SEATTLE TIMES' RESPONSE|
|Good medicine, bad journalism||Good journalism, bad critique|